FDA Letter API

Wewoka Animal Hospital

Letter data

Company
Wewoka Animal Hospital
Recipient
Dr. Rory G. Stricklin | Wewoka Animal Hospital | Robie Watters | 12821 Ns 3650 | Wewoka | , | OK | 74884 | United States
Issue date
2021-06-24
Posted date
Not available
FDA office
Division of Human and Animal Food Operations West III
Subject
Not available
Product
Animal & Veterinary
CMS ID
577595
Reference number
Not available
FEI
Not available
Inspection dates
Not available

Normalized citations

21 CFR: None found

21 U.S.C.: None found

Related FDA links

No related FDA letter link is present in the source index.

Full source text

CLOSEOUT LETTER Wewoka Animal Hospital MARCS-CMS 577595 — June 24, 2021 More Warning Letters Warning Letters About Warning and Close-Out Letters Delivery Method: UPS Overnight Product: Animal & Veterinary Recipient: Recipient Name Dr. Rory G. Stricklin Wewoka Animal Hospital Robie Watters 12821 Ns 3650 Wewoka , OK 74884 United States Issuing Office: Division of Human and Animal Food Operations West III United States Secondary Issuing Offices United States Dear Dr. Rory G. Stricklin: The Food and Drug Administration has completed an evaluation of your firm’s corrective actions in response to our Warning Letter (CMS #577595, dated June 3, 2019) issued following an inspection of your Wewonka Animal Hospital located at 12821 Ns 3650, Wewoka, Oklahoma 74884. Based on our evaluation, it appears that you have addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections. This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means. Sincerely, /S/ Jessica E. Havranek Director, Compliance Branch Human & Animal Food Operations, WD3 Content current as of: 12/15/2023 Regulated Product(s) Animal & Veterinary